≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Injection of e.g. viscoelastic gel into the vitreous cavity

PheWeb

DM_EYE_OPER_INJECT_GEL_VITR

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector
diagram bullet

Check conditions

DIABETES_FG

60969

diagram downward connector
diagram bullet

Filter registries

Operations: NOMESCO codes ^CKD15

195

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

195

diagram downward connector

Check minimum number of events None

195

diagram downward connector

Include endpoints None

195

diagram downward connector
DM_EYE_OPER_INJECT_GEL_VITR

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 195 78 117
Unadjusted prevalence (%) 0.05 0.04 0.07
Mean age at first event (years) 51.54 47.32 54.34

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: DM_EYE_OPER_INJECT_GEL_VITR – Injection of e.g. viscoelastic gel into the vitreous cavity
GWS hits:

Survival analyses between endpoints

↥

Plot

before Injection of e.g. viscoelastic gel into the vitreous cavity
after Injection of e.g. viscoelastic gel into the vitreous cavity

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Injection of e.g. viscoelastic gel into the vitreous cavity

↥